Literature DB >> 20071441

HIV RNA suppression rates after 24 weeks of treatment with etravirine, darunavir/ritonavir and raltegravir in the etravirine early access programme.

E Florence, S De Wit, A Castagna, E Ribera, A Hill, H Vanaken, Y van Delft, S Marks.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20071441     DOI： 10.1258/ijsa.2009.009425

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN： 0956-4624            Impact factor:   1.359


× No keyword cloud information.
  1 in total

1.  Antiretroviral regimens sparing agents from the nucleoside(tide) reverse transcriptase inhibitor class: a review of the recent literature.

Authors:  Amit C Achhra; Mark A Boyd
Journal:  AIDS Res Ther       Date:  2013-12-13       Impact factor: 2.250
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.